MedTech Investment Working Group – Q3 Meeting
AdvaMed Accel held the 3rd Quarter meeting of the MedTech Investment Working Group.
HPA Review of CY 2023 OPPS/ASC Proposed Rule Summary
During this meeting, HPA walked members through their summary of the CY 2023 OPPS/ASC proposed rule.
Reducing Regulatory Burden and Streamlining FDA Review Through ASCA Pilot Program Utilization
Join NAMSA and the FDA as they present a webinar on the Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program, a first-of-its-kind conformity assessment program created by the U.S. FDA.
MedTech Investment Working Group – Q2 Meeting
AdvaMed Accel held the 2nd Quarter meeting of the MedTech Investment Working Group.
